InvestorsObserver

ALLR Allarity Therapeutics Inc

$0.30 $0.00 (0.37%)
15 Minute Delayed Price Enable Real-Time Price
Overall

ALLR Stock Analysis Overview

What this means: Allarity Therapeutics Inc (ALLR) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives ALLR a rank of 2. Our methodology considers analysis of the company's financial situation and how it has traded recently. ALLR rank of 2 means that it ranks below 98% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

ALLR Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

ALLR Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

ALLR Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

ALLR Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

ALLR Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

ALLR Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

ALLR Stock Analysis Overview

What this means: Allarity Therapeutics Inc (ALLR) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives ALLR a rank of 2. Our methodology considers analysis of the company's financial situation and how it has traded recently. ALLR rank of 2 means that it ranks below 98% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full ALLR report

ALLR Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

ALLR Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

ALLR Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

ALLR Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

ALLR Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

ALLR Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Allarity Therapeutics Inc (ALLR) Analyst Forecast

ALLR Price, Volume, Earnings, and Dividend Date

  • Last Price $0.30
  • Previous Close $0.30
  • Change $0.00
  • Open $0.32
  • Volume 349,008
  • Avg. Volume (100-day) 982,359
  • Market Cap 1,860,464
  • Days Range 0.29 - 0.3201
  • 52-week Range 0.29 - 154.4
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS 2625.43
  • Earnings Date 05/09/24
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 1.323
  • PEG Ratio

Allarity Therapeutics Inc (ALLR) Company Description

Allarity Therapeutics Inc is a clinical-stage, precision medicine company.

Allarity Therapeutics Inc (ALLR) Stock Chart